In the future, we will continue to collect relevant samples of patients with colorectal cancer treated with immunotherapy and further study the correlation between PLAU and GSDMC expression and the prognosis of colorectal cancer patients treated with ICIs. The gene discussed is PLAU; the disease is colorectal cancer.